Clinical Pharmacokinetics of Narcotic Agonist-Antagonist Drugs

Overview of attention for article published in Clinical Pharmacokinetics, December 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

patent: 70 patents

Citations

dimensions_citation: 76 Dimensions

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 70 patents that reference this research output.

Clinical Pharmacokinetics of Narcotic Agonist-Antagonist Drugs

About this Attention Score

Mentioned by

Citations

Readers on

Tamper resistant oral opioid agonist formulations

Grant US-10588865-B2

United States of America

Pharmaceutical preparation containing oxycodone and naloxone

Grant US-10420762-B2

United States of America

Tamper resistant oral opioid agonist formulations

Grant US-10350173-B2

United States of America

Method and device for the assessment of bowel function

Grant US-10258235-B2

United States of America

Pharmaceutical products

Grant US-10092519-B2

United States of America

Combination of oxycodone and naloxone for use in treating pain in patients suffering from…

Grant US-10071089-B2

United States of America

Opioid agonist formulations with releasable and sequestered antagonist

Grant US-9949930-B2

United States of America

Pharmaceutical preparation containing oxycodone and naloxone

Grant US-9907793-B2

United States of America

Immediate release pharmaceutical compositions comprising oxycodone and naloxone

Grant US-9820983-B2

United States of America

Tamper resistant oral opioid agonist formulations

Grant US-9801828-B2

United States of America

Matrix for sustained, invariant and independent release of active compounds

Grant US-9655855-B2

United States of America

Method of providing sustained analgesia with buprenorphine

Grant US-9642850-B2

United States of America

Pharmaceutical preparation containing oxycodone and naloxone

Grant US-9555000-B2

United States of America

Abuse-resistant controlled-release opioid dosage form

Grant US-9511066-B2

United States of America

Abuse-resistant controlled-release opioid dosage form

Grant US-9480685-B2

United States of America

Opioid agonist/opioid antagonist/acetaminophen combinations

Grant US-9474750-B2

United States of America

Tamper-resistant oral opioid agonist formulations

Grant US-9456989-B2

United States of America

Abuse-resistant controlled-release opioid dosage form

Grant US-9358230-B1

United States of America

Abuse-resistant controlled-release opioid dosage form

Grant US-9345701-B1

United States of America

Abuse-resistant controlled-release opioid dosage form

Grant US-9283216-B2

United States of America

Abuse-resistant controlled-release opioid dosage form

Grant US-9283221-B2

United States of America

Tamper-resistant oral opioid agonist formulations

Grant US-9278073-B2

United States of America

Immediate release pharmaceutical compositions comprising oxycodone and naloxone

Grant US-9271940-B2

United States of America

Opioid agonist/antagonist combinations

Grant US-9205082-B2

United States of America

Abuse-resistant controlled-release opioid dosage form

Grant US-9168252-B2

United States of America